Measuring meningococcal vaccination coverage among adolescents in Italy: state-of-the-art and regional challenges

adolescents, meningococcal vaccine, Italy, vaccine coverage

1. Huang L, Heuer OD, Janßen S, Häckl D, Schmedt N. Clinical and economic burden of invasive meningococcal disease: Evidence from a large German claims database. PLoS ONE 2020;15(1): e0228020. https://doi.org/10.1371/journal.pone.0228020
2. Ferrara P, Stromillo L, Albano L. Awareness, attitudes, and practices toward Meningococcal B vaccine among pediatricians in Italy. Medicina 2018;54(6):100. doi: 10.3390/medicina54060100
3. Istituto Superiore di Sanità. Sorveglianza delle Malattie Batteriche Invasive in Italia – Rapporto consolidato 2019. Rome: ISS, 2020.
4. Ministero della Salute. Piano Nazionale della Prevenzione Vaccinale 2017-2019. Roma: Ministero della Salute, 2017.
5. Global Burden of Diseases 2020, Release 1, Vaccine Coverage Collaborators. Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1. The Lancet. 2021;398(10299):503-21. doi: 10.1016/S0140-6736(21)00984-3
6. Ministero della Salute. Vaccinazioni dell'età pediatrica e dell'adolescenza - Coperture vaccinali. Available at: https://www.salute.gov.it/portale/documentazione/p6_2_8_3_1.jsp?lingua=italiano&id=20 (last accessed on November 10, 2021)
7. Signorelli C, Odone A, Gianfredi V, Bossi E, Bucci D, Oradini-Alacreu A, et al. The spread of COVID-19 in six western metropolitan regions: a false myth on the excess of mortality in Lombardy and the defense of the city of Milan. Acta Biomed. 2020;91(2):23-30.
8. Balasco N, D'Alessandro V, Ferrara P, Smaldone G, Vitagliano L. Analysis of the time evolution of COVID-19 lethality during the first epidemic wave in Italy. Acta Biomed. 2021;92(2):e2021171.
9. Gianfredi V, Moretti M, Lopalco PL. Countering vaccine hesitancy through immunization information systems, a narrative review Hum Vaccin Immunother. 2019;15(11):2508-2526. doi: 10.1080/21645515.2019.1599675.
10. Gianfredi V, D'Ancona F, Maraglino F, et al. Polio and measles: reasons of missed vaccination in Italy, 2015-2017. Ann Ig. 2019;31(3):191-201. doi: 10.7416/ai.2019.2282.
11. D'Ancona F, Gianfredi V, Riccardo F, Iannazzo S. Immunisation Registries at regional level in Italy and the roadmap for a future Italian National Registry. Ann Ig. 2018 Mar-Apr;30(2):77-85. doi: 10.7416/ai.2018.2199.
12. Odone A, Gianfredi V, Sorbello S, et al. The Use of Digital Technologies to Support Vaccination Programmes in Europe: State of the Art and Best Practices from Experts’ Interviews. Vaccines 2021; 9:1126.
13. Cella P, Voglino G, Barberis I, et al. Resources for assessing parents' vaccine hesitancy: a systematic review of the literature. J Prev Med Hyg. 2020;61(3):E340-E373. doi: 10.15167/2421-4248/jpmh2020.61.3.1448.
14. Gianfredi V, Grisci C, Nucci D, et al. Recenti Prog Med [Communication in health]. 2018;109(7):374-383. doi: 10.1701/2955.29706.
15. Gianfredi V, Minerva M, Casu G, et al. Immediate adverse events following COVID-19 immunization. A cross-sectional study of 314,664 Italian subjects. Acta Biomed. 2021;92(S6):e2021487. doi: 10.23750/abm.v92iS6.12365.
16. Ponticelli D, Madotto F, Conti S, et al. Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up. Internal and Emergency Medicine 2021. doi: 10.1007/s11739-021-02857-y
17. Vigezzi GP, Lume A, Minerva M, Nizzero P, Biancardi A, Gianfredi V, Odone A, Signorelli C, Moro M. Safety surveillance after BNT162b2 mRNA COVID-19 vaccination: results from a cross-sectional survey among staff of a large Italian teaching hospital. Acta Biomed [Internet]. 2021;92(S6):e2021450.